Loading...
Fibrinogen fusion proteins, methods of making, and methods of using fibrinogen fusion proteins are described. In a preferred embodiment the fibrinogen fusion protein contains a truncated Aa chain of fibrinogen. The Aa chain contains truncation site, which is a deletion of amino acids at its C-terminal region. A non-fibrinogen protein or peptide is C-terminally attached to the truncation site. The fibrinogen fusion proteins can be used alone or mixed with native fibrinogen to form fibrin polymer.
Type
patent
EPO Family ID
37192477
Inventors
Note
Alternative title(s) : (de) Fibrinogenmolekülvarianten-fusionsproteine (fr) Variant moléculaire de protéines hybrides fibrinogènes
TTO classification
TTO:6.0600
Patent number | Country code | Kind code | Date issued |
US2010009409 | US | A1 | 2010-01-14 |
JP2009502166 | JP | A | 2009-01-29 |
EP1913144 | EP | A1 | 2008-04-23 |
WO2007015782 | WO | A1 | 2007-02-08 |
Available on Infoscience
September 22, 2015
Use this identifier to reference this record